News

Clinical investigation of medical devices for human subjects — Good clinical practice (GCP for Medical Devices) has undergone a significant review. The changes include; —

The latest Novotech snapshot of Australian #clinicaltrial activity has been released. It indicates there’s upwards of an 80% return to business across some of our

To rapidly and effectively test vaccines, they must be tested in regions where viral spread and case numbers are high. With Covid19, high incidence has

Another great session conducted as part of PRAXIS’ ongoing webinar series. A big thank-you to our sponsors Newline and Lockton Companies Australia for their support.

The call for greater investment in Australia’s R&D sector has again been made. Perhaps it’s never been more important than now, as our biotech industry

In the rush to find a treatment for #Covid19, we’ve seen a huge influx of new #clinicaltrials, largely of repurposed drugs. Many of these trials

6 new principles to replace the 3 R’s (replace,reduce,refine) in animal research. The new principles ask researchers to think more critically about their research and

Statement of Support  PRAXIS Australia is committed to supporting our Aboriginal and Torres Strait Islander friends, colleagues, and communities across Australia, and stand proudly alongside,

This story depicts an extended case of deliberate fraud and misconduct by an Investigator against a list of CROs and Pharmaceutical companies. Was the need

You may be aware of the much discussed retraction last week of the #Lancet article which claimed that hydroxychloroquine was associated with increased in-hospital mortality

In our PRAXIS Australia Ltd webinar today we talked about the growing role and importance of social media and artificial intelligence to support #clinicaltrialrecruitment and

Happy International Clinical Trials Day 2020! Today we celebrate the many ways #clinicaltrials have improved health outcomes for individuals and communities, and the people who make it